HC Surgical Specialists Limited (SGX:1B1)
0.3300
0.00 (0.00%)
At close: Aug 11, 2026
HC Surgical Specialists Balance Sheet
Financials in millions SGD. Fiscal year is June - May.
Millions SGD. Fiscal year is Jun - May.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash & Equivalents | 7.78 | 5.09 | 7.36 | 6.19 | 6.93 |
Short-Term Investments | - | 0.34 | 0.25 | 2.15 | 0.23 |
Trading Asset Securities | 0.31 | 0.64 | 0.7 | 2.19 | - |
Cash & Short-Term Investments | 8.08 | 6.07 | 8.32 | 10.53 | 7.16 |
Cash Growth | 33.25% | -27.07% | -21.02% | 47.03% | -35.86% |
Accounts Receivable | 1.37 | 1.23 | 1.13 | 1.26 | 1.21 |
Other Receivables | 0.83 | 0.33 | 0.5 | 0.22 | 0.12 |
Receivables | 2.2 | 1.56 | 1.63 | 1.48 | 1.32 |
Inventory | 0.37 | 0.42 | 0.37 | 0.45 | 0.38 |
Prepaid Expenses | 0.34 | 0.28 | 0.23 | 0.25 | 0.26 |
Other Current Assets | 0.38 | - | 0.34 | - | - |
Total Current Assets | 11.37 | 8.33 | 10.88 | 12.7 | 9.12 |
Property, Plant & Equipment | 3.41 | 3.75 | 3.98 | 4.5 | 3.88 |
Long-Term Investments | 11.76 | 9.95 | 9.04 | 9.15 | 12.59 |
Goodwill | 4.62 | 3.39 | 3.36 | 3.36 | 4.04 |
Other Intangible Assets | - | - | - | - | 0 |
Long-Term Deferred Tax Assets | 0.14 | 0.11 | 0.02 | 0.04 | 0.1 |
Other Long-Term Assets | 1.26 | 1.74 | 0.57 | 1.52 | 1.24 |
Total Assets | 32.56 | 27.27 | 27.84 | 31.26 | 30.96 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Accounts Payable | 4.36 | 0.14 | 0.09 | 0.07 | 0.15 |
Accrued Expenses | - | 2.25 | 2.25 | 2.16 | 2.18 |
Current Portion of Long-Term Debt | 0.02 | - | 1.29 | 1.26 | 1.24 |
Current Portion of Leases | 1.61 | 1.4 | 1.19 | 1.05 | 0.97 |
Current Income Taxes Payable | 0.55 | 0.57 | 0.97 | 1.01 | 1 |
Other Current Liabilities | 0.05 | 0.5 | 4.76 | 5.88 | 2.1 |
Total Current Liabilities | 6.6 | 4.85 | 10.54 | 11.43 | 7.65 |
Long-Term Debt | - | - | - | 1.29 | 2.55 |
Long-Term Leases | 1.07 | 1.39 | 1.86 | 1.9 | 1.49 |
Long-Term Deferred Tax Liabilities | 0.07 | 0.08 | 0.2 | 0.09 | 0.1 |
Other Long-Term Liabilities | 4.25 | 0.21 | 0.77 | 4.48 | 7.95 |
Total Liabilities | 11.98 | 6.52 | 13.37 | 19.18 | 19.74 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Common Stock | 17.23 | 17.23 | 17.23 | 15.42 | 15.42 |
Retained Earnings | 24.48 | 20.68 | 14.55 | 13.32 | 13.68 |
Treasury Stock | -1.12 | -1.12 | -1 | -1 | -1 |
Comprehensive Income & Other | -19.68 | -15.84 | -16.1 | -15.64 | -17.1 |
Total Common Equity | 20.91 | 20.95 | 14.69 | 12.1 | 11 |
Minority Interest | -0.33 | -0.2 | -0.22 | -0.02 | 0.22 |
Shareholders' Equity | 20.58 | 20.75 | 14.47 | 12.08 | 11.22 |
Total Liabilities & Equity | 32.56 | 27.27 | 27.84 | 31.26 | 30.96 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Total Debt | 2.7 | 2.78 | 4.34 | 5.5 | 6.25 |
Net Cash (Debt) | 5.39 | 3.28 | 3.98 | 5.03 | 0.91 |
Net Cash Growth | 64.12% | -17.53% | -20.92% | 453.19% | -70.84% |
Net Cash Per Share | 0.04 | 0.02 | 0.03 | 0.03 | 0.01 |
Filing Date Shares Outstanding | 153.38 | 153.38 | 153.81 | 148.89 | 148.89 |
Total Common Shares Outstanding | 153.38 | 153.38 | 153.81 | 148.89 | 148.89 |
Working Capital | 4.77 | 3.48 | 0.34 | 1.28 | 1.47 |
Book Value Per Share | 0.14 | 0.14 | 0.10 | 0.08 | 0.07 |
Tangible Book Value | 16.29 | 17.56 | 11.33 | 8.75 | 6.96 |
Tangible Book Value Per Share | 0.11 | 0.11 | 0.07 | 0.06 | 0.05 |
Machinery | - | 2.46 | 2.34 | 2.31 | 2.17 |